Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 4 3Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Ear Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Remifentanil × Clear all
NCT00405522 2019-03-08

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

The Hospital for Sick Children

Phase 3 Completed
34 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02093143 2014-03-20

ENDOTANIL

Centre Hospitalier Universitaire de Besancon

Phase 3 Completed
256 enrolled

Ear Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡